Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase

Yuxia Wang, Andreea Ticu Boeck, Ellen G. Duysen, Margaret Van Keuren, Thomas L. Saunders, Oksana Lockridge

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Organophosphorus toxicants (OP) include chemical nerve agents and pesticides. The goal of this work was to find out whether an animal could be made resistant to OP toxicity by genetic engineering. The human butyrylcholinesterase (BChE) mutant G117H was chosen for study because it has the unusual ability to hydrolyze OP as well as acetylcholine, and it is resistant to inhibition by OP. Human G117H BChE, under the control of the ROSA26 promoter, was expressed in all tissues of transgenic mice. A stable transgenic mouse line expressed 0.5 μg/ml of human G117H BChE in plasma as well as 2 μg/ml of wild-type mouse BChE. Intestine, kidneys, stomach, lungs, heart, spleen, liver, brain, and muscle expressed 0.6-0.15 μg/g of G117H BChE. Transgenic mice were normal in behavior and fertility. The LD50 dose of echothiophate for wild-type mice was 0.1 mg/kg sc. This dose caused severe cholinergic signs of toxicity and lethality in wild-type mice, but caused no deaths and only mild toxicity in transgenic animals. The mechanism of protection was investigated by measuring acetylcholinesterase (AChE) and BChE activity. It was found that AChE and endogenous BChE were inhibited to the same extent in echothiophate-treated wild type and transgenic mice. This led to the hypothesis that protection against echothiophate toxicity was not explained by hydrolysis of echothiophate. In conclusion, the transgenic G117H BChE mouse demonstrates the factors required to achieve protection from OP toxicity in a vertebrate animal.

Original languageEnglish (US)
Pages (from-to)356-366
Number of pages11
JournalToxicology and Applied Pharmacology
Volume196
Issue number3
DOIs
StatePublished - May 1 2004

Fingerprint

Butyrylcholinesterase
Transgenic Mice
Toxicity
Animals
Acetylcholinesterase
Genetic engineering
Genetically Modified Animals
Aptitude
Genetic Engineering
Lethal Dose 50
Pesticides
Liver
Cholinergic Agents
Acetylcholine
Intestines
Fertility
Muscle
Vertebrates
Hydrolysis
Brain

Keywords

  • Butyrylcholinesterase
  • Echothiophate
  • Insecticide Resistance
  • Organophosphorus
  • Organophosphorus toxicants
  • Pesticide resistance
  • Transgenic mice
  • Transgenic mouse

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase. / Wang, Yuxia; Boeck, Andreea Ticu; Duysen, Ellen G.; Van Keuren, Margaret; Saunders, Thomas L.; Lockridge, Oksana.

In: Toxicology and Applied Pharmacology, Vol. 196, No. 3, 01.05.2004, p. 356-366.

Research output: Contribution to journalArticle

Wang, Yuxia ; Boeck, Andreea Ticu ; Duysen, Ellen G. ; Van Keuren, Margaret ; Saunders, Thomas L. ; Lockridge, Oksana. / Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase. In: Toxicology and Applied Pharmacology. 2004 ; Vol. 196, No. 3. pp. 356-366.
@article{588d95ef2a864b02ace2b300b94087f1,
title = "Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase",
abstract = "Organophosphorus toxicants (OP) include chemical nerve agents and pesticides. The goal of this work was to find out whether an animal could be made resistant to OP toxicity by genetic engineering. The human butyrylcholinesterase (BChE) mutant G117H was chosen for study because it has the unusual ability to hydrolyze OP as well as acetylcholine, and it is resistant to inhibition by OP. Human G117H BChE, under the control of the ROSA26 promoter, was expressed in all tissues of transgenic mice. A stable transgenic mouse line expressed 0.5 μg/ml of human G117H BChE in plasma as well as 2 μg/ml of wild-type mouse BChE. Intestine, kidneys, stomach, lungs, heart, spleen, liver, brain, and muscle expressed 0.6-0.15 μg/g of G117H BChE. Transgenic mice were normal in behavior and fertility. The LD50 dose of echothiophate for wild-type mice was 0.1 mg/kg sc. This dose caused severe cholinergic signs of toxicity and lethality in wild-type mice, but caused no deaths and only mild toxicity in transgenic animals. The mechanism of protection was investigated by measuring acetylcholinesterase (AChE) and BChE activity. It was found that AChE and endogenous BChE were inhibited to the same extent in echothiophate-treated wild type and transgenic mice. This led to the hypothesis that protection against echothiophate toxicity was not explained by hydrolysis of echothiophate. In conclusion, the transgenic G117H BChE mouse demonstrates the factors required to achieve protection from OP toxicity in a vertebrate animal.",
keywords = "Butyrylcholinesterase, Echothiophate, Insecticide Resistance, Organophosphorus, Organophosphorus toxicants, Pesticide resistance, Transgenic mice, Transgenic mouse",
author = "Yuxia Wang and Boeck, {Andreea Ticu} and Duysen, {Ellen G.} and {Van Keuren}, Margaret and Saunders, {Thomas L.} and Oksana Lockridge",
year = "2004",
month = "5",
day = "1",
doi = "10.1016/j.taap.2003.12.018",
language = "English (US)",
volume = "196",
pages = "356--366",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase

AU - Wang, Yuxia

AU - Boeck, Andreea Ticu

AU - Duysen, Ellen G.

AU - Van Keuren, Margaret

AU - Saunders, Thomas L.

AU - Lockridge, Oksana

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Organophosphorus toxicants (OP) include chemical nerve agents and pesticides. The goal of this work was to find out whether an animal could be made resistant to OP toxicity by genetic engineering. The human butyrylcholinesterase (BChE) mutant G117H was chosen for study because it has the unusual ability to hydrolyze OP as well as acetylcholine, and it is resistant to inhibition by OP. Human G117H BChE, under the control of the ROSA26 promoter, was expressed in all tissues of transgenic mice. A stable transgenic mouse line expressed 0.5 μg/ml of human G117H BChE in plasma as well as 2 μg/ml of wild-type mouse BChE. Intestine, kidneys, stomach, lungs, heart, spleen, liver, brain, and muscle expressed 0.6-0.15 μg/g of G117H BChE. Transgenic mice were normal in behavior and fertility. The LD50 dose of echothiophate for wild-type mice was 0.1 mg/kg sc. This dose caused severe cholinergic signs of toxicity and lethality in wild-type mice, but caused no deaths and only mild toxicity in transgenic animals. The mechanism of protection was investigated by measuring acetylcholinesterase (AChE) and BChE activity. It was found that AChE and endogenous BChE were inhibited to the same extent in echothiophate-treated wild type and transgenic mice. This led to the hypothesis that protection against echothiophate toxicity was not explained by hydrolysis of echothiophate. In conclusion, the transgenic G117H BChE mouse demonstrates the factors required to achieve protection from OP toxicity in a vertebrate animal.

AB - Organophosphorus toxicants (OP) include chemical nerve agents and pesticides. The goal of this work was to find out whether an animal could be made resistant to OP toxicity by genetic engineering. The human butyrylcholinesterase (BChE) mutant G117H was chosen for study because it has the unusual ability to hydrolyze OP as well as acetylcholine, and it is resistant to inhibition by OP. Human G117H BChE, under the control of the ROSA26 promoter, was expressed in all tissues of transgenic mice. A stable transgenic mouse line expressed 0.5 μg/ml of human G117H BChE in plasma as well as 2 μg/ml of wild-type mouse BChE. Intestine, kidneys, stomach, lungs, heart, spleen, liver, brain, and muscle expressed 0.6-0.15 μg/g of G117H BChE. Transgenic mice were normal in behavior and fertility. The LD50 dose of echothiophate for wild-type mice was 0.1 mg/kg sc. This dose caused severe cholinergic signs of toxicity and lethality in wild-type mice, but caused no deaths and only mild toxicity in transgenic animals. The mechanism of protection was investigated by measuring acetylcholinesterase (AChE) and BChE activity. It was found that AChE and endogenous BChE were inhibited to the same extent in echothiophate-treated wild type and transgenic mice. This led to the hypothesis that protection against echothiophate toxicity was not explained by hydrolysis of echothiophate. In conclusion, the transgenic G117H BChE mouse demonstrates the factors required to achieve protection from OP toxicity in a vertebrate animal.

KW - Butyrylcholinesterase

KW - Echothiophate

KW - Insecticide Resistance

KW - Organophosphorus

KW - Organophosphorus toxicants

KW - Pesticide resistance

KW - Transgenic mice

KW - Transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=1942439688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942439688&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2003.12.018

DO - 10.1016/j.taap.2003.12.018

M3 - Article

C2 - 15094306

AN - SCOPUS:1942439688

VL - 196

SP - 356

EP - 366

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -